2015 Report details for project: Brighton & Sussex University Hospitals NHS Trust - 3Ts Programme

Project name: Brighton & Sussex University Hospitals NHS Trust - 3Ts Programme - there are 3 reports for this project: 2013, 2014, 2015
Google search: Google search on project name (opens in new window) opens in new window
Organisation: DOH (D12) - see all reports for this organisation
Report year: 2015 (data is from Sept 2014)
Category: Infrastructure - see all reports for this category
Description: 1. Replacement of the Barry Building at the Royal Sussex County Hospital. The building was opened in 1828 and contains 200 medical and care of the elderly beds (with circa 5% single rooms), plus the main hospital imaging department and other diagnostic and treatment facilities; 2. The transfer of the regional neurosciences centre from Hurstwood Park (on the Princess Royal Hospital campus which is also part of the Trust). The building is over 70 years old. The project will create the capacity to treat patients from Sussex in Sussex (many currently travel into London); 3. The creation of a Major Trauma Centre for the South East region in line with policy; 4. The expansion of the Sussex Cancer Centre to enable Sussex patients to be treated in Sussex for non-surgical procedures; 5. Provision of teaching and research facilities for Brighton & Sussex Medical School.
DCA (RAG): Amber/Green
DCA text: The MPA RAG rating was Amber/Green at Q2 2014. The Trust has undertaken, with its Programme Board, a RAG assessment of the "Common Causes of Project Failure" in relation to the progress of the project at Q2. The Programme Board discussed this in detail and were clear about the RAG ratings which were provided for each category. Once all the ratings were taken together, the overall assessment was Amber/Green: many of the key points had been addressed in the preparation for FBC approval, based on the OBC approval which was granted in May 2014. The key areas of higher risk/lower confidence rating related mainly to stakeholder engagement and support (given that the commissioner landscape has changed significantly since commissioners provided the original OBC support letters). There has been extensive engagement with commissioners through a NHS England Area Team-led Commissioner Oversight Forum to ensure that commissioners are sufficiently engaged with, and involved in, the assumptions relating to activity and income which underpin the Business Case. Since May 2014, the NHS Trust Development Authority has convened a National Programme Board and National Working Group which includes commissioners and approving bodies to ensure that all key stakeholders in the process are working together.
Start date: 2012-01-27
End date: 2021-12-24
Schedule text: The Trust had an approved OBC from HMT in May 2014. This was two years later than originally planned. This delay was due to several factors, the main one being the requirement to secure planning permission prior to submission. Planning consent was achieved in January 2012. The OBC was subsequently re-approved by NHS SEC after which the DH/MT approval process was set in motion. Following the OBC approval the Trust completed the FBC which was approved by the Trust Board in September 2014 and then submitted to the TDA in October. Market testing continued throughout this period in order for the GMP to be ready as stated in the summer of 2015. The decant programme also continued and is due to be completed at the end of 2015. FBC approval by the TDA is pending following the recent Board meeting .
Baseline: £28.13m
Forecast: £33.75m
Variance: 20.00%
Variance text: Variance of 20% is mainly caused by CDEL (24% variance) which is a result of comparing different programmes (budgeted programme vs forecast programme). Programmes will be different due to delays in approval of business cases and approval of Trust loans. The underlying cashflows follow the programmes and in the GMPP return it can be seen that other years will have similar and opposite variances eg 2015/16 is -67%, 2016/17 -20%, 2017/18 is +61% etc. It can also be seen in the Q2 GMPP return that the outturn forecast is equal to budget based on the approved OBC.
Whole Life Cost: £445.76m
WLCost text: This remain based on Q2 2014/15 which reflect approved OBC. These may be amended upon approval of Full Business Case depending on prevailing market conditions.
Notes1: Brighton & Sussex University Hospitals NHS Trust (3Ts Programme - The development of a leading teaching, trauma and tertiary care centre) DOH CAPITAL
Notes2:
Sourcefile: IPA_2015.csv

Home Selection Search All Reports All Projects (+dates) All Projects (+costs) All Organisations All Years All Categories


Acknowledgement: GMPP data has been re-used under the Open Government Licence.